Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Eli Lilly and Abbisko Announce Drug Development Collaboration
In today's Pharmaceutical Executive Daily, Eli Lilly and Abbisko Therapeutics announce a new strategic research collaboration in which Abbisko will l…
2 weeks, 5 days ago
Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts
In today's Pharmaceutical Executive Daily, the FDA announces Operation TrialBlazer, a pilot program aimed at cutting early-stage clinical trial timel…
2 weeks, 6 days ago
Pharmaceutical Executive Daily: AbbVie Acquires Apogee Therapeutics for $10.9 Billion
In today's Pharmaceutical Executive Daily, AbbVie announces a $10.9 billion agreement to acquire Apogee Therapeutics, adding a suite of clinical-stag…
3 weeks ago
Pharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010
In today's Pharmaceutical Executive Daily, an FDA advisory committee votes unanimously in favor of the benefit-risk profile of Moderna's investigatio…
3 weeks, 3 days ago
Pharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxive
In today's Pharmaceutical Executive Daily, Biogen announces its second acquisition of 2026, a deal worth up to $1 billion for private immunology biot…
3 weeks, 4 days ago
Pharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programs
In today's Pharmaceutical Executive Daily, FDA staff release briefing documents flagging evidence gaps in Moderna's mRNA flu vaccine, a pharma roundu…
3 weeks, 5 days ago
Pharmaceutical Executive Daily: FDA has Approved Skinvive by Juvéderm
In today's Pharmaceutical Executive Daily, Elicio Therapeutics shares tumble after its Phase II Amplifgy-7P trial of KRAS-targeting immunotherapy ELI…
3 weeks, 6 days ago
Pharmaceutical Executive Daily: FDA Approves Two Indications of Keytruda in Combination with Welireg
In today's Pharmaceutical Executive Daily, Boehringer Ingelheim's Brian Hilberdink argues that obesity innovation must evolve beyond the scale, a pha…
4 weeks ago
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO
In today's Pharmaceutical Executive Daily, Kardigan sets terms for a $350 million IPO that would value the cardiovascular biotech at approximately $1…
1 month ago
Pharmaceutical Executive Daily: China's Latest Policy Guidance
In today's Pharmaceutical Executive Daily, Bruce Liu examines China's latest policy guidance establishing premium pricing and priority reimbursement …
1 month ago